Guardian Pharmacy Services, Inc. reported its financial results for the first quarter of 2026, revealing a revenue increase of 2.2% to $336.6 million compared to $329.3 million in the same period of 2025. The company’s net income rose significantly to $13.5 million, up from $9.3 million year-over-year, reflecting a 45.5% increase. This growth in profitability was attributed to improved gross profit margins, which increased from $64.3 million to $76.3 million, despite a rise in selling, general, and administrative expenses from $51.3 million to $58.6 million.
The company experienced notable operational changes, including the conversion of 13.5 million shares of Class B common stock into Class A common stock during the quarter. Additionally, Guardian Pharmacy completed a follow-on public offering in March 2026, raising $30.3 million, which was used to repurchase shares of Class A common stock. The company’s total equity increased from $217.9 million at the end of 2025 to $232.4 million by March 31, 2026, reflecting a strong capital position.
Operationally, Guardian Pharmacy expanded its reach, serving approximately 207,000 residents across 8,400 long-term care facilities (LTCFs) in 38 states, an increase from 189,000 residents in the previous year. The number of prescriptions dispensed also grew from 6.7 million to 7.4 million. However, organic revenue decreased by $11.2 million, primarily due to pricing pressures resulting from the Inflation Reduction Act, which impacted the cost of goods sold.
The company’s cash and cash equivalents stood at $64.9 million as of March 31, 2026, with no outstanding principal under its term loan or line of credit. Guardian Pharmacy's management expressed confidence in its ability to meet future capital needs through existing cash flows and available credit. Looking ahead, the company aims to continue its growth strategy through both organic expansion and acquisitions, while navigating the challenges posed by regulatory changes in the pharmaceutical landscape.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. provides technology-enabled pharmacy services tailored for long-term care facilities, including assisted living and behavioral health settings. It specializes in medication management, compliance packaging, clinical support, and data analytics to improve resident outcomes, reduce errors, and lower healthcare costs. Serving approximately 186,000 residents across 7,000 LTCFs nationwide, it leverages automation, local management, and strategic growth to maintain a competitive position in the institutional pharmacy market.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.